In fact, the non-transcriptional role of BRD4 in controlling DNA damage checkpoint activation and repair, as well as telomere maintenance, has been proposed, providing a new perspective on the multiple functions of the protein and opening up new prospects for BET inhibitor’s application in cancer [11]. Here, BRD4 is linked to cancer.